1. Home
  2. CDXS vs BKTI Comparison

CDXS vs BKTI Comparison

Compare CDXS & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • BKTI
  • Stock Information
  • Founded
  • CDXS 2002
  • BKTI 1997
  • Country
  • CDXS United States
  • BKTI United States
  • Employees
  • CDXS N/A
  • BKTI N/A
  • Industry
  • CDXS Major Chemicals
  • BKTI Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CDXS Industrials
  • BKTI Technology
  • Exchange
  • CDXS Nasdaq
  • BKTI Nasdaq
  • Market Cap
  • CDXS 254.3M
  • BKTI 247.9M
  • IPO Year
  • CDXS 2010
  • BKTI N/A
  • Fundamental
  • Price
  • CDXS $2.44
  • BKTI $74.92
  • Analyst Decision
  • CDXS Buy
  • BKTI Strong Buy
  • Analyst Count
  • CDXS 2
  • BKTI 1
  • Target Price
  • CDXS $11.00
  • BKTI $74.00
  • AVG Volume (30 Days)
  • CDXS 1.1M
  • BKTI 64.8K
  • Earning Date
  • CDXS 10-30-2025
  • BKTI 11-13-2025
  • Dividend Yield
  • CDXS N/A
  • BKTI N/A
  • EPS Growth
  • CDXS N/A
  • BKTI 292.72
  • EPS
  • CDXS N/A
  • BKTI 3.06
  • Revenue
  • CDXS $57,164,000.00
  • BKTI $78,326,000.00
  • Revenue This Year
  • CDXS $12.88
  • BKTI $11.20
  • Revenue Next Year
  • CDXS $21.64
  • BKTI $10.66
  • P/E Ratio
  • CDXS N/A
  • BKTI $24.40
  • Revenue Growth
  • CDXS N/A
  • BKTI 4.63
  • 52 Week Low
  • CDXS $1.90
  • BKTI $19.48
  • 52 Week High
  • CDXS $6.08
  • BKTI $76.04
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 37.30
  • BKTI 68.19
  • Support Level
  • CDXS $2.37
  • BKTI $67.59
  • Resistance Level
  • CDXS $2.54
  • BKTI $70.42
  • Average True Range (ATR)
  • CDXS 0.12
  • BKTI 3.40
  • MACD
  • CDXS -0.01
  • BKTI -0.40
  • Stochastic Oscillator
  • CDXS 30.00
  • BKTI 88.95

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About BKTI BK Technologies Corporation

BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.

Share on Social Networks: